The rising interest in GLP-1 agonists for diabetes has sparked a discussion about formats: skin-applied devices versus capsules. Traditionally , GLP-1 therapies were solely available in oral form, but the https://aoifeyfwf469349.jaiblogs.com/68005443/glp-1-skin-applications-vs-oral-medications-what-best-for-individuals